Methods useful in the treatment of bone resorption diseases

The invention relates to a combined pharmaceutical preparation comprising parathyroid hormone and a bone resorption inhibitor, said preparation being adapted for (a) the administration of parathyroid hormone during a period of approximately 6 to 24 months; (b) after the administration of parathyroid hormone has been terminated, the administration of a bone…

Source: http://www.freshpatents.com/-dt20120614ptan20120148684.php

Dipeptidy See here Look at here

Related posts:

1. JAK Inhibitors especially in the age-related osteoporotic bone
2. NART methods physeal St changes Hypoxia and determination
3. Hordenine a study with an endpoint of the treatment completion rate of capecitabine
4. Nepafenac 78281-72-8 expression was decreased in the case F after treatment